College Station, Texas / Accesswire / February 28, 2023 / Enzolytics, Inc. (OTC PINK: ENZC) (https://enzolytics.com/).
Enzolytics, Inc. has completed the onboarding process with Amazon (www.amazon.com) allow IPF Immune direct sales and distribution through the Amazon platform for IPF Immune™ dietary supplements. Enzolytics’ direct selling account with Amazon allows us to benefit from the substantial profits and promotional benefits offered by being a direct seller on the Amazon platform. The company’s IPF Immune is shipping to Amazon fulfillment centers and will be available on Amazon.com once the product is integrated into Amazon’s systems.
The company’s product promotion plan addresses each of the key requirements for financial success of new products and the steps required for successful new products. (3) effective promotion to introduce the product to consumers; Our plan meets each of these requirements. IPF Immune is an effective product, promoted through channels such as Amazon and other national distributors, and brought to market and promoted by our distributor, Nutritional Products International (NPI).
Amazon is the largest US online retailer with 37.8% of the US e-commerce market. IPF Immune products are also offered on multiple e-commerce platforms and are strategically focused on tapping the $50 billion annual nutritional supplement market. Today, over 70% of Americans are more concerned with their health, and IPF Immune meets that need. Given the beneficial properties of the product and our ability to significantly promote it through our distributors NPI, we expect great success from the product. In addition, the company continues to plan to market its products outside the United States throughout Europe and South America.
Our distributor, Nutritional Products International (NPI), is a Florida-based global brand management company with the reach and expertise to successfully place IPF Immune in the market. NPI CEO Mitch Gould said: Wellness, sports nutrition products.IHM oversees his TV tagging campaigns nationwide, along with public relations and social media strategies aimed at increasing brand awareness. ”
NPI recently announced the hiring of Joseph Mies as National Account Manager. Mies is the founder of Muscle Foods USA and a legend in the sports nutrition sector. Under his leadership, Muscle Foods has become the largest and fastest growing sports nutrition distributor in the United States. ”
Muscle Foods has become the nation’s leading sports nutrition distributor for performance stores, convenience stores, gyms, health clubs, health food stores, and e-commerce sites. After becoming a division of Eurpac Service Inc., Mies built Muscle Foods into a powerful company by 2021. ”
Enzolytics CEO Charles Cotropia said: You will have great success. ”
At Enzolytics, we are committed to helping you reach your full potential. IPF Immune strengthens the body’s natural immune system. The job of the immune system is to defend against disease-causing microbes. Its goal is to keep us healthy. The immune system is a vast and complex network of interconnected organs, cells, and proteins that work together to protect the body from disease. A healthy immune system can defeat invading disease-causing bacteria and pathogens such as bacteria, viruses, parasites, chemicals and cancer cells while protecting healthy tissues.”
Diseases and viruses can be dealt with more effectively by strengthening the body’s natural defense mechanisms.The body’s natural immune system needs help for many reasons. Possibly, infections such as the flu and other viruses can weaken the immune system. It can also weaken. Therefore, strengthening the body’s innate immune system makes the body’s natural performance more effective. ”
The company’s CSO, Harry Zhabilov, added: Wholesome Ingredients. Manufactured through a patented formula designed to support the body’s natural immune function. We believe it will be widely accepted by consumers.
safe harbor declaration: This news release contains risks and uncertainties related to financial forecasts, budgets, milestone timelines, clinical development, regulatory approvals and other risks that Enzolytics, Inc. describes in its periodic reports. It contains forward-looking statements. seconds.
Although Enzolytics believes that its forward-looking statements and the underlying assumptions contained therein are reasonable, any of the assumptions may be inaccurate. This includes any disease or condition, the development of research and strategies leading to commercialization of its therapeutics in the United States, the acquisition of funds necessary to carry out the development plan, the timely completion of research and testing; or complete at all, and the successful outcome of such research or testing. Therefore, no assurance can be given that the forward-looking statements contained in this release are accurate.
Such forward-looking statements are based on current expectations. They involve inherent risks and uncertainties, including those that could delay, adapt or alter any of the statements presented and could cause actual results or results to differ materially from current expectations. increase. Forward-looking statements cannot be guaranteed. These forward-looking statements are made as of the date of this press release. We expressly disclaim any intention or obligation to update any forward-looking statements or why actual results may differ from those projected by the forward-looking statements.
Company Contact:
Enzolytics Inc.
1101 Raintree Circle
Allen, Texas 75013
www.enzolytics.com
sauce: Enzolytics Inc.
